title: JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients.
authors.forename: L
authors.initials: L
authors.lastname: Florensa
authors.forename: B
authors.initials: B
authors.lastname: Bellosillo
authors.forename: C
authors.initials: C
authors.lastname: Besses
authors.forename: E
authors.initials: E
authors.lastname: Puigdecanet
authors.forename: B
authors.initials: B
authors.lastname: Espinet
authors.forename: E
authors.initials: E
authors.lastname: Pérez-Vila
authors.forename: R
authors.initials: R
authors.lastname: Longarón
authors.forename: R M
authors.initials: RM
authors.lastname: Vilà
authors.forename: F
authors.initials: F
authors.lastname: Solé
authors.forename: S
authors.initials: S
authors.lastname: Serrano
mesh_terms: D001792:Blood Platelets / Q000201:enzymology / Q000473:pathology; D019070:Cell Lineage; D004252:DNA Mutational Analysis; D015672:Erythroid Precursor Cells; D006098:Granulocytes / Q000201:enzymology / Q000473:pathology; D006801:Humans; D053614:Janus Kinase 2; D022423:Myeloid Cells / Q000201:enzymology* / Q000473:pathology; D017354:Point Mutation; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D013920:Thrombocythemia, Essential / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2